Neil John Mchugh
#162,265
Most Influential Person Now
Neil John Mchugh's AcademicInfluence.com Rankings
Neil John Mchughphilosophy Degrees
Philosophy
#9400
World Rank
#12954
Historical Rank
Logic
#6380
World Rank
#7892
Historical Rank

Neil John Mchughbiology Degrees
Biology
#12927
World Rank
#16435
Historical Rank
Immunology
#874
World Rank
#897
Historical Rank

Download Badge
Philosophy Biology
Neil John Mchugh's Degrees
- Doctorate Medicine Harvard University
- PhD Immunology Stanford University
Why Is Neil John Mchugh Influential?
(Suggest an Edit or Addition)Neil John Mchugh's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Treatment recommendations for psoriatic arthritis (2008) (796)
- Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis (2016) (764)
- A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma. (2006) (663)
- European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies (2011) (477)
- BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic lupus erythematosus. (2005) (473)
- Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis (2010) (367)
- Corrigendum: Dense genotyping of immune-related susceptibility loci reveals new insights into the genetics of psoriatic arthritis (2015) (365)
- Development and initial validation of an updated version of the British Isles Lupus Assessment Group ’ s disease activity index for patients with systemic lupus erythematosus (2005) (352)
- European multicentre study to define disease activity criteria for systemic sclerosis.* II. Identification of disease activity variables and development of preliminary activity indexes (2001) (320)
- Psoriatic arthritis: outcome of disease subsets and relationship of joint disease to nail and skin disease. (1994) (316)
- Progression of peripheral joint disease in psoriatic arthritis: a 5-yr prospective study. (2003) (315)
- A randomized placebo-controlled trial of methotrexate in psoriatic arthritis (2012) (313)
- British Association of Dermatologists guidelines for use of biological interventions in psoriasis 2005 (2005) (288)
- Myositis-specific autoantibodies: their clinical and pathogenic significance in disease expression. (2009) (274)
- Group for Research and Assessment of Psoriasis and Psoriatic Arthritis/Outcome Measures in Rheumatology Consensus‐Based Recommendations and Research Agenda for Use of Composite Measures and Treatment Targets in Psoriatic Arthritis (2018) (255)
- The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project) (2012) (246)
- Development and Assessment of a Computerized Index of Clinical Disease Activity in Systemic Lupus Erythematosus (1988) (217)
- Clinical associations of autoantibodies to a p155/140 kDa doublet protein in juvenile dermatomyositis. (2007) (203)
- International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trials (2016) (175)
- Quantitative nailfold capillaroscopy findings in a population with connective tissue disease and in normal healthy controls. (1996) (167)
- Dense genotyping of immune-related susceptibility loci reveals new insights into the genetics of psoriatic arthritis (2015) (162)
- A polymorphism in the CTGF promoter region associated with systemic sclerosis. (2007) (159)
- The use of Systemic Lupus Erythematosus Disease Activity Index-2000 to define active disease and minimal clinically meaningful change based on data from a large cohort of systemic lupus erythematosus patients (2010) (159)
- Autoantibodies in myositis (2018) (147)
- The EuroMyositis registry: an international collaborative tool to facilitate myositis research (2017) (146)
- Anti-MDA5 autoantibodies in juvenile dermatomyositis identify a distinct clinical phenotype: a prospective cohort study (2014) (141)
- Comparison of three screening tools to detect psoriatic arthritis in patients with psoriasis (CONTEST study) (2013) (139)
- Axial Disease in Psoriatic Arthritis study: defining the clinical and radiographic phenotype of psoriatic spondyloarthritis (2016) (135)
- Identification of a novel autoantibody directed against small ubiquitin-like modifier activating enzyme in dermatomyositis. (2007) (134)
- Smoking and delay to diagnosis are associated with poorer functional outcome in psoriatic arthritis (2013) (132)
- Calcinosis in juvenile dermatomyositis is influenced by both anti-NXP2 autoantibody status and age at disease onset (2014) (128)
- The clinical and genetic associations of anti-cyclic citrullinated peptide antibodies in psoriatic arthritis. (2005) (126)
- The ClASsification for Psoriatic ARthritis (CASPAR) Criteria – A Retrospective Feasibility, Sensitivity, and Specificity Study (2012) (126)
- Numerical scoring for the BILAG-2004 index (2010) (124)
- A Transcriptional Signature of Fatigue Derived from Patients with Primary Sjögren’s Syndrome (2015) (122)
- Nailfold Videocapillaroscopic Features and Other Clinical Risk Factors for Digital Ulcers in Systemic Sclerosis: A Multicenter, Prospective Cohort Study (2016) (119)
- Confirmation of TNIP1 and IL23A as susceptibility loci for psoriatic arthritis (2011) (117)
- Prevention of vascular damage in scleroderma and autoimmune Raynaud's phenomenon: a multicenter, randomized, double-blind, placebo-controlled trial of the angiotensin-converting enzyme inhibitor quinapril. (2007) (116)
- European multicentre study to define disease activity criteria for systemic sclerosis.* I. Clinical and epidemiological features of 290 patients from 19 centres (2001) (114)
- Development and assessment of a computerized index of clinical disease activity in systemic lupus erythematosus. Members of the British Isles Lupus Assessment Group (BILAG). (1988) (113)
- HLA class II haplotype and autoantibody associations in children with juvenile dermatomyositis and juvenile dermatomyositis-scleroderma overlap. (2007) (113)
- Guideline for anti-TNF-α therapy in psoriatic arthritis (2005) (112)
- Therapies for peripheral joint disease in psoriatic arthritis. A systematic review. (2006) (112)
- Interaction of HLA-DRB1*03 and smoking for the development of anti-Jo-1 antibodies in adult idiopathic inflammatory myopathies: a European-wide case study (2011) (107)
- Percutaneous screw fixation of acetabular fractures with CT guidance: preliminary results of a new technique. (1992) (107)
- Novel autoantibodies and clinical phenotypes in adult and juvenile myositis (2011) (106)
- The BILAG-2004 index is sensitive to change for assessment of SLE disease activity (2009) (104)
- Effectiveness of adalimumab in treating patients with active psoriatic arthritis and predictors of good clinical responses for arthritis, skin and nail lesions (2009) (103)
- Lipoproteins and their subfractions in psoriatic arthritis: identification of an atherogenic profile with active joint disease (2000) (102)
- International multicenter psoriasis and psoriatic arthritis reliability trial for the assessment of skin, joints, nails, and dactylitis. (2009) (102)
- Work disability in psoriatic arthritis: a systematic review. (2012) (97)
- British isles lupus assessment group 2004 index is valid for assessment of disease activity in systemic lupus erythematosus (2007) (97)
- Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS) (2017) (97)
- Autoantibodies in juvenile-onset myositis: Their diagnostic value and associated clinical phenotype in a large UK cohort (2017) (96)
- Improvement in patient-reported outcomes for patients with ankylosing spondylitis treated with etanercept 50 mg once-weekly and 25 mg twice-weekly. (2007) (96)
- Clinical Utility of Random Anti–Tumor Necrosis Factor Drug–Level Testing and Measurement of Antidrug Antibodies on the Long‐Term Treatment Response in Rheumatoid Arthritis (2015) (95)
- Risk Factors for Clinical Coronary Heart Disease in Systemic Lupus Erythematosus: The Lupus and Atherosclerosis Evaluation of Risk (LASER) Study (2010) (94)
- Infusion of iloprost, a prostacyclin analogue, for treatment of Raynaud's phenomenon in systemic sclerosis. (1988) (94)
- Health-related utility values of patients with primary Sjögren's syndrome and its predictors (2013) (92)
- Revised British Isles Lupus Assessment Group 2004 index: a reliable tool for assessment of systemic lupus erythematosus activity. (2006) (90)
- Updating the Psoriatic Arthritis (PsA) Core Domain Set: A Report from the PsA Workshop at OMERACT 2016 (2017) (86)
- The 2012 BSR and BHPR guideline for the treatment of psoriatic arthritis with biologics. (2013) (85)
- Arthropathy of hands and feet in systemic lupus erythematosus. (1990) (83)
- Statin-induced necrotizing myositis - a discrete autoimmune entity within the "statin-induced myopathy spectrum". (2013) (82)
- Evidence to support IL-13 as a risk locus for psoriatic arthritis but not psoriasis vulgaris (2011) (80)
- Drug Therapies for Peripheral Joint Disease in Psoriatic Arthritis: A Systematic Review (2014) (77)
- Adult and juvenile dermatomyositis: are the distinct clinical features explained by our current understanding of serological subgroups and pathogenic mechanisms? (2013) (77)
- Muscle Biopsy Findings in Combination With Myositis‐Specific Autoantibodies Aid Prediction of Outcomes in Juvenile Dermatomyositis (2016) (77)
- Low-dose aspirin vs low-dose aspirin plus low-intensity warfarin in thromboprophylaxis: a prospective, multicentre, randomized, open, controlled trial in patients positive for antiphospholipid antibodies (ALIWAPAS). (2014) (75)
- Associations of erosive arthritis with anti-cyclic citrullinated peptide antibodies and MHC Class II alleles in systemic lupus erythematosus. (2008) (72)
- PTPN22 is associated with susceptibility to psoriatic arthritis but not psoriasis: evidence for a further PsA-specific risk locus (2015) (72)
- Variants in RUNX3 contribute to susceptibility to psoriatic arthritis, exhibiting further common ground with ankylosing spondylitis. (2013) (71)
- Tumour necrosis factor inhibitor monotherapy vs combination with MTX in the treatment of PsA: a systematic review of the literature. (2015) (70)
- Evidence for unique association signals in SLE at the CD28-CTLA4-ICOS locus in a family-based study. (2006) (69)
- Tumour necrosis factor‐α polymorphism and the HLA‐Cw*0602 allele in psoriatic arthritis (2002) (69)
- Mortality in Psoriatic Arthritis – A Single-center Study from the UK (2010) (69)
- Fatigue in primary Sjögren's syndrome is associated with lower levels of proinflammatory cytokines (2016) (68)
- The Influence of the HLA-DRB1 rheumatoid arthritis shared epitope on the clinical characteristics and radiological outcome of psoriatic arthritis. (2003) (68)
- Guideline for anti-TNF-alpha therapy in psoriatic arthritis. (2005) (65)
- Psoriatic arthritis: clinical subgroups and histocompatibility antigens. (1987) (65)
- Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus: results from the British Isles Lupus Assessment Group Biologics Register (2017) (63)
- Reduced joint counts misclassify patients with oligoarticular psoriatic arthritis and miss significant numbers of patients with active disease. (2013) (63)
- Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): Treatment Recommendations for Psoriatic Arthritis 2015 (2015) (61)
- Focused HLA analysis in Caucasians with myositis identifies significant associations with autoantibody subgroups (2019) (61)
- The diagnostic utility of autoantibodies in adult and juvenile myositis (2013) (60)
- BILAG-2004 index captures systemic lupus erythematosus disease activity better than SLEDAI-2000 (2007) (60)
- Factors influencing work disability in psoriatic arthritis: first results from a large UK multicentre study. (2015) (59)
- Interval between onset of psoriasis and psoriatic arthritis comparing the UK Clinical Practice Research Datalink with a hospital-based cohort (2017) (58)
- Pregnancy outcome and autoantibodies in connective tissue disease. (1989) (57)
- Anticardiolipin and antineutrophil antibodies in giant cell arteritis. (1990) (57)
- The temporal relationship between cancer and adult onset anti-transcriptional intermediary factor 1 antibody–positive dermatomyositis (2018) (57)
- Observational Study of Treatment Outcome in Early Diffuse Cutaneous Systemic Sclerosis (2010) (57)
- Increasing incidence of immune-mediated necrotizing myopathy: single-centre experience. (2015) (56)
- Comparison of infrared thermography and laser speckle contrast imaging for the dynamic assessment of digital microvascular function. (2012) (56)
- A Multicenter Study of the Validity and Reliability of Responses to Hand Cold Challenge as Measured by Laser Speckle Contrast Imaging and Thermography (2018) (55)
- The reliability of immunoassays to detect autoantibodies in patients with myositis is dependent on autoantibody specificity (2020) (54)
- Multinational Qualitative Research Study Exploring the Patient Experience of Raynaud's Phenomenon in Systemic Sclerosis (2018) (54)
- HLA-DR antigens and anticardiolipin antibodies in patients with systemic lupus erythematosus. (1989) (54)
- Lack of agreement between rheumatologists in defining digital ulceration in systemic sclerosis. (2009) (54)
- Cross-phenotype association mapping of the MHC identifies genetic variants that differentiate psoriatic arthritis from psoriasis (2017) (52)
- Newly identified autoantibodies: relationship to idiopathic inflammatory myopathy subsets and pathogenesis (2008) (52)
- Mortality in systemic sclerosis—a single centre study from the UK (2013) (50)
- Serum Soluble Bone Turnover Biomarkers in Psoriatic Arthritis and Psoriatic Spondyloarthropathy (2015) (50)
- Use of infrared thermography as an endpoint in therapeutic trials of Raynaud's phenomenon and systemic sclerosis. (2012) (49)
- Variants in linkage disequilibrium with the late cornified envelope gene cluster deletion are associated with susceptibility to psoriatic arthritis (2010) (49)
- Connective Tissue Disease and Autoantibodies in the Kindreds of 63 Patients with Systemic Sclerosis (1993) (48)
- Use of Laser Speckle Contrast Imaging to Assess Digital Microvascular Function in Primary Raynaud Phenomenon and Systemic Sclerosis: A Comparison Using the Raynaud Condition Score Diary (2015) (48)
- Endothelin axis polymorphisms in patients with scleroderma. (2006) (47)
- Tumour necrosis factor-alpha polymorphism and the HLA-Cw*0602 allele in psoriatic arthritis. (2002) (47)
- Interleukin 1α, interleukin 1β and interleukin 1 receptor gene polymorphisms in psoriatic arthritis (2004) (47)
- Important Treatment Outcomes for Patients with Psoriatic Arthritis: A Multisite Qualitative Study (2017) (47)
- Modifiable risk factors and the development of psoriatic arthritis in people with psoriasis (2018) (46)
- Non organ based laboratory markers in systemic sclerosis. (2003) (45)
- Exploring ankylosing spondylitis-associated ERAP1, IL23R and IL12B gene polymorphisms in subphenotypes of psoriatic arthritis. (2013) (44)
- Patterns and predictors of skin score change in early diffuse systemic sclerosis from the European Scleroderma Observational Study (2018) (44)
- The effect of pregnancy on the onset of psoriatic arthritis. (1989) (44)
- Anti-topoisomerase I antibodies in silica-associated systemic sclerosis. A model for autoimmunity. (1994) (44)
- MHC class II, tumour necrosis factor α, and lymphotoxin α gene haplotype associations with serological subsets of systemic lupus erythematosus (2005) (43)
- Comparison of Three Immunoassays for the Detection of Myositis Specific Antibodies (2019) (43)
- HLA-DPB1 associations differ between DRB1*03 positive anti-Jo-1 and anti-PM-Scl antibody positive idiopathic inflammatory myopathy. (2009) (43)
- Influence of the cold challenge on the discriminatory capacity of the digital distal-dorsal difference in the thermographic assessment of Raynaud's phenomenon. (2011) (41)
- Disability, fatigue, pain and their associates in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (2017) (41)
- Comprehensive assessment of rheumatoid arthritis susceptibility loci in a large psoriatic arthritis cohort (2012) (41)
- Drug use and toxicity in psoriatic disease: focus on methotrexate. (2008) (41)
- Expression of the cutaneous lymphocyte antigen and its counter-receptor E-selectin in the skin and joints of patients with psoriatic arthritis. (1997) (41)
- Risk of uveitis and inflammatory bowel disease in people with psoriatic arthritis: a population-based cohort study (2017) (40)
- Serologic abnormalities in systemic sclerosis. (1999) (40)
- PsAID12 Provisionally Endorsed at OMERACT 2018 as Core Outcome Measure to Assess Psoriatic Arthritis-specific Health-related Quality of Life in Clinical Trials (2018) (38)
- A systematic review and meta-analysis to inform cancer screening guidelines in idiopathic inflammatory myopathies (2021) (38)
- Numerical scoring for the Classic BILAG index (2009) (38)
- Enhanced Patient Involvement and the Need to Revise the Core Set — Report from the Psoriatic Arthritis Working Group at OMERACT 2014 (2015) (36)
- Predictors of health-related quality of life and fatigue in systemic sclerosis: evaluation of the EuroQol-5D and FACIT-F assessment tools (2012) (36)
- Development of a Disease Severity and Responder Index for Psoriatic Arthritis (PsA) — Report of the OMERACT 10 PsA Special Interest Group (2011) (36)
- Presence of anti-eukaryotic initiation factor-2B, anti-RuvBL1/2 and anti-synthetase antibodies in patients with anti-nuclear antibody negative systemic sclerosis (2018) (36)
- Characterization of antinucleolar antibody reactivity in patients with systemic sclerosis and their relatives. (1997) (36)
- Human leukocyte antigen class II associations with systemic sclerosis in South Africans. (2004) (36)
- Development of a Disease Activity and Responder Index for Psoriatic Arthritis — Report of the Psoriatic Arthritis Module at OMERACT 11 (2014) (36)
- Association of markers for TGFβ3, TGFβ2 and TIMP1 with systemic sclerosis (2000) (35)
- 'It's more scary not to know': a qualitative study exploring the information needs of patients with systemic lupus erythematosus at the time of diagnosis. (2011) (35)
- Factors Associated With Sustained Remission in Rheumatoid Arthritis in Patients Treated With Anti–Tumor Necrosis Factor (2017) (35)
- Patient Involvement in Outcome Measures for Psoriatic Arthritis (2014) (35)
- Presentation of SLE in UK primary care using the Clinical Practice Research Datalink (2017) (35)
- Joint and soft tissue injections: a survey of general practitioners. (2005) (35)
- Mortality and Causes of Death in Psoriatic Arthritis (2012) (34)
- Validation of the Psoriatic Arthritis Impact of Disease (PsAID) Questionnaire and its potential as a single-item outcome measure in clinical practice (2017) (33)
- Anti-HMGCR Autoantibodies in Juvenile Idiopathic Inflammatory Myopathies Identify a Rare but Clinically Important Subset of Patients (2017) (33)
- Comparison of Etanercept Monotherapy and Combination Therapy with Methotrexate in Psoriatic Arthritis: Results from 2 Clinical Trials (2016) (33)
- Maximum blood flow and microvascular regulatory responses in systemic sclerosis. (2007) (33)
- Psoriatic arthritis--emerging concepts. (2001) (33)
- Composite Measures in Psoriatic Arthritis: GRAPPA 2008 (2010) (31)
- Patient-reported outcome instruments for assessing Raynaud’s phenomenon in systemic sclerosis: A SCTC vascular working group report (2018) (31)
- Myositis Specific and Associated Autoantibodies in the Diagnosis and Management of Juvenile and Adult Idiopathic Inflammatory Myopathies (2014) (30)
- Serum bone-turnover biomarkers are associated with the occurrence of peripheral and axial arthritis in psoriatic disease: a prospective cross-sectional comparative study (2017) (30)
- Microparticle subpopulations are potential markers of disease progression and vascular dysfunction across a spectrum of connective tissue disease (2016) (30)
- Genetic association study of NF-κB genes in UK Caucasian adult and juvenile onset idiopathic inflammatory myopathy (2011) (30)
- Apoptosis-new clues to the pathogenesis of Sjögren's syndrome? (2000) (30)
- The cervical spine in psoriatic arthritis: a clinical and radiological study. (1994) (29)
- Tumor necrosis factor promoter polymorphism TNF*-857 is a risk allele for psoriatic arthritis independent of the PSORS1 locus. (2011) (29)
- Histological heterogeneity in a large clinical cohort of juvenile idiopathic inflammatory myopathy: analysis by myositis autoantibody and pathological features (2019) (29)
- Autoantibodies to mitochondrial and centromere antigens in primary biliary cirrhosis and systemic sclerosis (1990) (29)
- Expression of myxovirus‐resistance protein A: a possible marker of muscle disease activity and autoantibody specificities in juvenile dermatomyositis (2018) (29)
- Characterisation of anticytoplasmic antibodies and their clinical associations. (1995) (29)
- Polymorphisms in IL-1B distinguish between psoriasis of early and late onset. (2014) (29)
- Pathogenic mechanisms of disease in myositis: autoantigens as clues (2009) (28)
- Anticardiolipin and antinuclear antibodies in cancer patients--a case control study. (2000) (28)
- Eligibility for clinical trials in primary Sjögren's syndrome: lessons from the UK Primary Sjögren's Syndrome Registry. (2015) (28)
- Effect of anti‐TNF and conventional synthetic disease‐modifying anti‐rheumatic drug treatment on work disability and clinical outcome in a multicentre observational cohort study of psoriatic arthritis (2016) (27)
- Atypical Behçet's disease with peripheral erosive arthropathy and pyoderma gangrenosum. (1992) (27)
- The contribution of platelets to the pathogenesis of Raynaud's phenomenon and systemic sclerosis (2013) (26)
- Anti-HMGCR Autoantibodies in Juvenile Idiopathic Inflammatory Myopathies Identify a Rare but Clinically Important Subset of Patients (2017) (26)
- Report of the GRAPPA-OMERACT Psoriatic Arthritis Working Group from the GRAPPA 2015 Annual Meeting (2016) (26)
- Arthritis in Idiopathic Inflammatory Myopathy: Clinical Features and Autoantibody Associations (2014) (25)
- Lupus-like syndrome associated with the use of minocycline. (1994) (25)
- Developing classification criteria for peripheral joint psoriatic arthritis. Step I. Establishing whether the rheumatologist's opinion on the diagnosis can be used as the "gold standard". (2006) (25)
- Do the EULAR Sjögren's syndrome outcome measures correlate with health status in primary Sjögren's syndrome? (2015) (25)
- Feasibility, Reliability, and Sensitivity to Change of Four Radiographic Scoring Methods in Patients With Psoriatic Arthritis (2014) (25)
- Psoriatic Arthritis Mutilans: Characteristics and Natural Radiographic History (2015) (25)
- Fatigue in primary Sjögren’s syndrome (pSS) is associated with lower levels of proinflammatory cytokines: a validation study (2019) (24)
- Familial scleroderma--evidence for environmental versus genetic trigger. (1994) (24)
- Predictors, demographics and frequency of sustained remission and low disease activity in anti-tumour necrosis factor–treated rheumatoid arthritis patients (2019) (24)
- The evidence for immunotherapy in dermatomyositis and polymyositis: a systematic review (2015) (23)
- Interleukin 1alpha, interleukin 1beta and interleukin 1 receptor gene polymorphisms in psoriatic arthritis. (2004) (23)
- Systemic lupus erythematosus and dysregulated apoptosis-what is the evidence? (2002) (23)
- Risk of type 2 diabetes and cardiovascular disease in an incident cohort of people with psoriatic arthritis: a population-based cohort study (2018) (23)
- Brief Report: Anti–Eukaryotic Initiation Factor 2B Autoantibodies Are Associated With Interstitial Lung Disease in Patients With Systemic Sclerosis (2016) (22)
- Development and Testing of New Candidate Psoriatic Arthritis Screening Questionnaires Combining Optimal Questions From Existing Tools (2014) (21)
- Implications of the diversity of class I HLA associations in psoriatic arthritis. (2016) (20)
- The impact of group education on participants' management of their disease in lupus and scleroderma. (2004) (20)
- The association of primary biliary cirrhosis and systemic sclerosis is not accounted for by cross reactivity between mitochondrial and centromere antigens. (1994) (20)
- The performance of the European League Against Rheumatism/American College of Rheumatology idiopathic inflammatory myopathies classification criteria in an expert-defined 10 year incident cohort (2018) (19)
- A Multicenter Nominal Group Study to Rank Outcomes Important to Patients, and Their Representation in Existing Composite Outcome Measures for Psoriatic Arthritis (2017) (18)
- Symptoms of Raynaud’s phenomenon (RP) in fibromyalgia syndrome are similar to those reported in primary RP despite differences in objective assessment of digital microvascular function and morphology (2016) (18)
- The promise, perceptions, and pitfalls of immunoassays for autoantibody testing in myositis (2020) (18)
- A rare coding allele in IFIH1 is protective for psoriatic arthritis (2017) (18)
- HLA-DQB1 associations with anti-topoisomerase-1 antibodies in patients with systemic sclerosis and their first degree relatives. United Kingdom Systemic Sclerosis Study Group. (1994) (17)
- A polymorphism in the promoter region of the CD86 (B7.2) gene is associated with systemic sclerosis (2006) (17)
- Pulmonary artery hypertension as the presenting feature of systemic sclerosis sine scleroderma. (2008) (17)
- Polymyositis: is there anything left? A retrospective diagnostic review from a tertiary myositis centre. (2020) (17)
- Papular lesions and cutaneous lupus erythematosus: a comparative clinical and histological study using monoclonal antibodies. (1988) (16)
- Investigation of IL1, VEGF, PPARG and MEFV genes in psoriatic arthritis susceptibility (2011) (16)
- A novel assay to measure B cell responses to keyhole limpet haemocyanin vaccination in healthy volunteers and subjects with systemic lupus erythematosus (2013) (16)
- Evaluation of the Economic Burden of Psoriatic Arthritis and the Relationship Between Functional Status and Healthcare Costs (2019) (16)
- Identification of a novel autoantigen eukaryotic initiation factor 3 associated with polymyositis (2019) (16)
- Frequency of autoantibodies to a major epitope on the carboxyl terminal fragment of CENP-B in patients with autoimmune disease. (1995) (15)
- Segregation of autoantibodies with disease in monozygotic twin pairs discordant for systemic sclerosis. Three further cases. (1995) (15)
- Early Psoriatic Arthritis. (2015) (15)
- Antinuclear Antibodies and Clinical Associations in a British Cohort with Limited Cutaneous Systemic Sclerosis (2011) (15)
- Psoriatic Nail Dystrophy Is Associated with Erosive Disease in the Distal Interphalangeal Joints in Psoriatic Arthritis: A Retrospective Cohort Study (2018) (14)
- MHC class II associations with autoantibody and T cell immune responses to the scleroderma autoantigen topoisomerase I. (2000) (14)
- A prospective study of pregnancy outcome in women screened at a routine antenatal clinic for anticardiolipin antibodies (1993) (14)
- Other seronegative spondyloarthropathies (2002) (13)
- Patient Participation in Psoriasis and Psoriatic Arthritis Outcome Research: A Report from the GRAPPA 2013 Annual Meeting (2014) (13)
- HLA – DPB 1 associations differ between DRB 1 * 03 positive anti-Jo-1 and anti-PM-Scl antibody positive idiopathic inflammatory myopathy (2009) (12)
- The BILAG-2004 systems tally—a novel way of representing the BILAG-2004 index scores longitudinally (2012) (12)
- Autoantibodies to the p140 Autoantigen NXP-2 in Adult Dermatomyositis (2009) (12)
- Abnormal cardiac enzymes in systemic sclerosis: a report of four patients and review of the literature (2014) (12)
- Trajectory of radiographic change over a decade: the effect of transition from conventional synthetic disease-modifying antirheumatic drugs to anti-tumour necrosis factor in patients with psoriatic arthritis (2018) (11)
- Polyarthritis and angioimmunoblastic lymphadenopathy. (1987) (11)
- Antiphospholipid syndrome with proliferative vasculopathy and bowel infarction. (2000) (11)
- Outcomes of the 2019 GRAPPA Workshop on Continuous Composite Indices for the Assessment of Psoriatic Arthritis and Membership-recommended Next Steps (2020) (11)
- Replication of a distinct psoriatic arthritis risk variant at the IL23R locus (2016) (11)
- Pain and depression are associated with both physical and mental fatigue independently of comorbidities and medications in primary Sjögren’s syndrome (2019) (11)
- Defining anti-synthetase syndrome: a systematic literature review. (2022) (11)
- Connective tissue disease and autoantibodies in the kindreds of 63 patients with systemic sclerosis. The United Kingdom Systemic Sclerosis Study Group. (1993) (10)
- HLA class II restriction of autoantibody production in patients with systemic lupus erythematosus. (1991) (10)
- Microvascular responses following digital thermal hyperaemia and iontophoresis measured by laser Doppler imaging in idiopathic inflammatory myopathy. (2007) (10)
- Treatment Algorithms for Early Psoriatic Arthritis: Do They Depend on Disease Phenotype? (2012) (10)
- Building Bridges between Researchers and Patient Research Partners: A Report from the GRAPPA 2014 Annual Meeting (2015) (10)
- Comparison of ESSDAI and ClinESSDAI in potential optimisation of trial outcomes in primary Sjögren's syndrome: examination of data from the UK Primary Sjögren's Syndrome Registry. (2018) (10)
- 'To suddenly have a name for this thing… was wonderful': the patient's experience of receiving a diagnosis of systemic lupus erythematosus. (2012) (10)
- Association of markers for TGFbeta3, TGFbeta2 and TIMP1 with systemic sclerosis. (2000) (9)
- Clinical Associations Of Anti-p140 Autoantibodies In Adult Myositis (2010) (9)
- Joint count reliability in psoriatic arthritis observational trials--an unreported problem. (2012) (9)
- Spontaneous neutrophil activation in patients with primary Raynaud's phenomenon and systemic sclerosis. (1992) (9)
- Verna Wright Lecture: Psoriatic Arthritis: The Need for Early Intervention (2015) (9)
- Genetic factors in psoriatic arthritis (2005) (8)
- Developing standardised treatment for adults with myositis and different phenotypes: an international survey of current prescribing preferences. (2016) (8)
- Vacuum-assisted closure therapy: a novel treatment for wound healing in systemic sclerosis. (2011) (8)
- Gender stratified adjustment of the DAS28-CRP improves inter-score agreement with the DAS28-ESR in rheumatoid arthritis (2018) (7)
- Frequency and clinical associations of anti-chromo antibodies in connective tissue disease. (1994) (7)
- Diagnosis and initial management in psoriatic arthritis: a qualitative study with patients (2019) (7)
- The myositis clinical phenotype associated with anti-Zo autoantibodies: a case series of nine UK patients (2019) (7)
- Eligibility for clinical trials in primary Sjögren's syndrome: lessons from the UK Primary Sjögren's Syndrome Registry. (2017) (7)
- Estimating the diagnostic accuracy of rheumatoid factor in UK primary care: a study using the Clinical Practice Research Datalink. (2015) (7)
- Novel Composite Radiographic Score for Longitudinal Observational Studies of Psoriatic Arthritis: A Proof-of-concept Study (2016) (7)
- Clinical Phenotypes of Caucasian Adult and Juvenile Dermatomyositis Patients with Anti-MDA5 Autoantibodies. (2012) (7)
- Minocycline-induced lupus and autoimmune phenomena (1999) (7)
- Investigation of myositis and scleroderma specific autoantibodies in patients with lung cancer (2018) (6)
- Tumor Necrosis Factor Inhibitor Monotherapy Versus Combination Therapy for the Treatment of Psoriatic Arthritis: Combined Analysis of European Biologics Databases (2020) (6)
- NEGATIVE RHEUMATOID FACTOR IN PRIMARY CARE DELAYS REFERRAL OF PATIENTS WITH RHEUMATOID ARTHRITIS (2014) (6)
- Combined corticosteroid and aspirin treatment for the high risk lupus pregnancy (1993) (6)
- Review of the Psoriatic Arthritis Working Group at OMERACT 12: A Report from the GRAPPA 2014 Annual Meeting (2015) (6)
- Myositis autoantibodies: recent perspectives (2020) (6)
- A Commercial Anti-TIF1γ ELISA Is Superior to Line and Dot Blot and Should Be Considered as Part of Routine Myositis-Specific Antibody Testing (2022) (6)
- Composite Measures for Clinical Trials in Psoriatic Arthritis: Testing Pain and Fatigue Modifications in a UK Multicenter Study (2021) (6)
- Evidence for Psoriatic Arthritis Impact of Disease (PsAID12) as Core Instrument to Measure Health-Related Quality of Life in Psoriatic Arthritis: A Systematic Review of Psychometric Properties (2019) (6)
- Association of a complement receptor 1 gene variant with baseline erythrocyte sedimentation rate levels in patients starting anti-TNF therapy in a UK rheumatoid arthritis cohort: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort (2013) (6)
- MUSCLE BIOPSY IN COMBINATION WITH MYOSITIS-SPECIFIC AUTOANTIBODIES AIDS PREDICTION OF OUTCOMES IN JUVENILE DERMATOMYOSITIS (2016) (6)
- HLA class II restriction of autoantibody production in patients with systematic lupus erythematosus (2004) (6)
- Comparative Genetic Analysis of Psoriatic Arthritis and Psoriasis for the Discovery of Genetic Risk Factors and Risk Prediction Modeling (2022) (6)
- The Clinical Aspects of Autoantibodies (2012) (6)
- Reactivity in ELISA with DNA-loaded nucleosomes in patients with proliferative lupus nephritis. (2015) (6)
- Elevated anticardiolipin antibodies in a patient with vibration-white-finger, valvular heart disease and psoriatic arthritis (1993) (6)
- Application of information theoretic feature selection and machine learning methods for the development of genetic risk prediction models (2021) (6)
- Autoantibodies in connective tissuedisease. (2019) (5)
- British Society for Rheumatology guideline on management of paediatric, adolescent and adult patients with idiopathic inflammatory myopathy (2022) (5)
- Impact of anti-centromere antibodies on pulmonary function test results in patients with systemic sclerosis without established or suspected pulmonary disease (2014) (5)
- Epidemiology of systemic sclerosis in the UK: an analysis of the Clinical Practice Research Datalink. (2020) (5)
- Evaluating factors influencing screening for pulmonary hypertension in systemic sclerosis: does disparity between available guidelines influence clinical practice? (2012) (5)
- Bilateral hip replacements in a man with cystic fibrosis and episodic arthritis. (1997) (5)
- Early response to anti-TNF predicts long-term outcomes including sustained remission: an analysis of the BSRBR-RA (2019) (5)
- Guidelines for the Treatment of Psoriatic Arthritis with Biologics the British Society for Rheumatology 2012 Guidelines for the Treatment of Psoriatic Arthritis with Biologics (5)
- Systematic protein-protein interaction and pathway analyses in the idiopathic inflammatory myopathies (2016) (4)
- Attitudes Toward Patient-Reported Outcome Instruments for the Assessment of Raynaud’s Phenomenon in Systemic Sclerosis (2016) (4)
- Anti-EIF2B: A Novel Interstitial Lung Disease Associated Autoantibody in Patients with Systemic Sclerosis (2012) (4)
- The Relationship Between the Vitamin D Receptor Gene and Anti-155/140 Antibodies in UK Caucasians with Idiopathic Inflammatory Myositis (2009) (4)
- Morphoea profunda and its relationship to eosinophilic fasciitis (2018) (4)
- Identification and prediction of novel classes of long-term disease trajectories for patients with juvenile dermatomyositis using growth mixture models (2020) (4)
- Exploring the illness representations of people with psoriatic arthritis: a secondary analysis of focus group data (2018) (4)
- Long-term effectiveness of tumour necrosis factor-α inhibitor treatment for psoriatic arthritis in the UK: a multicentre retrospective study (2018) (4)
- Serological subsets of juvenile idiopathic inflammatory myopathies - an update (2016) (4)
- Subgroups in psoriatic arthritis. (1994) (4)
- BSRBR-RA Contributors Group (2019). Predictors, demographics and frequency of sustained remission and low disease activity in anti-tumour necrosis factor-treated rheumatoid arthritis patients. Rheumatology (2019) (4)
- Using Bayesian networks to identify musculoskeletal symptoms influencing the risk of developing psoriatic arthritis in people with psoriasis (2021) (3)
- A surprise behind a case of winter vomiting virus (2013) (3)
- Clinical Differences Between Adult and Juvenile Dermatomyositis Associated with Anti-NXP2 Autoantibodies. (2012) (3)
- Proceedings of the 23rd Paediatric Rheumatology European Society Congress: part two (2017) (3)
- Features and recommended treatment of systemic sclerosis (2008) (3)
- Oral Abstracts 1: Connective Tissue DiseaseO1. Long-Term Outcomes of Children Born to Mothers with SLE (2013) (3)
- Pregnancy loss, menopause, and the onset of rheumatoid arthritis. (1990) (3)
- 049. INTERVAL BETWEEN ONSET OF PSORIASIS AND PSORIATIC ARTHRITIS: COMPARING THE UNITED KINGDOM CLINICAL PRACTICE RESEARCH DATALINK WITH A HOSPITAL-BASED COHORT (2017) (3)
- Biologic Agents in Psoriasis: British Association of Dermatologists' Guidelines for Biologic Intervention for Psoriasis 2009 (2011) (3)
- The potential overlapping populations for treatment with belimumab and rituximab using current NHS England and National Institute for Health and Care Excellence Guidelines in England and Wales. (2017) (3)
- Oral Abstracts 7: RA ClinicalO37. Long-Term Outcomes of Early RA Patients Initiated with Adalimumab Plus Methotrexate Compared with Methotrexate Alone Following a Targeted Treatment Approach (2013) (3)
- Evaluation and Validation of a Patient-completed Psoriatic Arthritis Flare Questionnaire (2021) (3)
- Traditional Schemes for Treatment of Psoriatic Arthritis (2009) (3)
- METHOTREXATE IS NOT DISEASE MODIFYING IN PSORIATIC ARTHRITIS: A NEW TREATMENT PARADIGM IS REQUIRED (2010) (3)
- Current management of dermatomyositis (2012) (3)
- Treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs: British Society for Rheumatology guideline scope. (2020) (2)
- The 66/68 Joint Count for the Measurement of MSK Disease Activity/Peripheral Joint Activity in Psa: A Grappa-Omeract Working Group Initiative (2018) (2)
- Clinical associations of autoantibodies to a p155/140 KDA doublet in adult and juvenile dermatomyositis (2007) (2)
- 181. Developing Standardized Treatment for Adults with Myositis and Different Phenotypes (2014) (2)
- PC23 MAXIMUM HYPERAEMIC RESPONSE AS A BIOLOGICAL REFERENCE FOR LASER DOPPLER BLOOD FLOW MEASUREMENTS (2004) (2)
- Sub-phenotyping of juvenile dermatomyositis: can it assist clinical decisions? (2014) (2)
- How good are the eular sjögren’s syndrome disease activity index, and eular sjögren’s syndrome patients reported index in predicting health status in primary sjögren’s syndrome? (2012) (2)
- 262 Longitudinal Assessment of Systemic Lupus Erythematosus Disease Activity: British Isles Lupus Assessment Group 2004, Systemic Lupus Erythematosus Disease Activity Index 2000 or Both? (2016) (2)
- Role of ANA and Myositis Autoantibodies in Diagnosis (2019) (2)
- Test Data in General Practice Are Not Missing at Random - Can We Identify When They Are? (2013) (2)
- Lessons for clinical practice from biologics registers IP10. Establishing and Running a Biologics Register: Manchester - United (2011) (2)
- 175 Myositis-Specific Autoantibodies Rarely Coexist with Each Other: An Analysis of the Ukmyonet and Eumyonet Cohorts (2016) (2)
- 17. Anti-synthetase autoantibody is seen in patients with overlap myositis in the UK cohort of patients with Jveunile Dermatomyositis (2017) (2)
- 174 A diagnostic and treatment challenge: the prevalence and clinical associations of anti-HMG-CoA reductase autoantibodies in a large UK juvenile-onset myositis cohort (2016) (2)
- Comparison of Three Screening Tools in Psoriatic Arthritis: The Contest Study (2012) (2)
- The Diagnostic Accuracy Of Rheumatoid Factor Testing In Primary Care (2013) (2)
- Outcomes of children born to mothers with systemic lupus erythematosus exposed to hydroxychloroquine or azathioprine (2022) (2)
- Atypical antineutrophil cytoplasmic antibodies in patients with ankylosing spondylitis. (1995) (2)
- Anti‐Golgi autoantibodies: prevalence and disease associations in a rheumatic disease population (2012) (2)
- O44. An Integrative Analytical Approach to Subphenotyping of Juvenile Dermatomyositis (2015) (2)
- Identification of autoantibodies to a novel autoantigen protein complex (EIF3) in polymyositis patients (2011) (2)
- Corrigendum to: A systematic review and meta-analysis to inform cancer screening guidelines in idiopathic inflammatory myopathies (2021) (2)
- Longitudinal profiling of the gut microbiome in patients with psoriatic arthritis and ankylosing spondylitis: a multicentre, prospective, observational study (2020) (1)
- 053. ANTI-SYNTHETASE AUTOANTIBODY IS SEEN IN PATIENTS WITH OVERLAP MYOSITIS IN THE UK COHORT OF PATIENTS WITH JUVENILE DERMATOMYOSITIS (2017) (1)
- Conventional therapy of psoriatic arthritis: evidence-based review. (2011) (1)
- Comment on: The temporal relationship between cancer and adult onset anti-transcriptional intermediary factor 1 antibody–positive dermatomyositis: Reply (2019) (1)
- Gene-Environmental Interaction of HLA-DRB1*03:01 and Smoking for the Development of Anti-Jo-1 Autoantibodies in Idiopathic Inflammatory Myopathies: A UK Study (2016) (1)
- Chapter 11 – Clinical Outcome Measures in Psoriatic Arthritis (2007) (1)
- ANTI-NXP2 AUTOANTIBODY STATUS IS A PREDICTOR OF CALCINOSIS IN OLDER BUT NOT YOUNGER CHILDREN WHO DEVELOP JUVENILE DERMATOMYOSITIS (2013) (1)
- Impaired digital vascular function mimicking Raynaud's phenomenon as a complication of argon laser therapy in tuberous sclerosis. (2010) (1)
- Composite Measures for Routine Clinical Practice in Psoriatic Arthritis: Testing of Shortened Versions in a UK Multicenter Study. (2021) (1)
- Raynaud’s phenomenon and macrocytic anaemia (2010) (1)
- FRI0674 Applicability of the psaid12 questionnaire as a core outcome measurement in psa clinical trials: an evaluation using omeract filter 2.1 instrument selection criteria (2018) (1)
- Basic (PS01–PS58) (2012) (1)
- BHPR research: qualitative1. Complex reasoning determines patients’ perception of outcome following foot surgery in rheumatoid arhtritis (2012) (1)
- Clinical and immunogenetic characteristics of patients with Autoantibodies to small ubiquitin-like modifier activating enzyme in dermatomyositis (2008) (1)
- Composite Measures for Routine Clinical Practice in Psoriatic Arthritis: Testing of Shortened Versions in a UK Multicenter Study (2021) (1)
- The 2022 British Society for Rheumatology guideline for the treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs. (2022) (1)
- AB0735 SEVERITY OF NAIL PSORIASIS SCORE (SNAPS) DEMONSTRATES LONGITUDINAL CONSTRUCT VALIDITY AGAINST THE MODIFIED NAIL PSORIASIS SEVERITY INDEX (mNAPSI) IN AN OBSERVATIONAL COHORT OF PATIENTS WITH PSORIATIC ARTHRITIS (2020) (1)
- Corrigendum: Eligibility for clinical trials in primary Sjögren's syndrome: Lessons from the UK Primary Sjögren's Syndrome Registry [Rheumatology, 55, (2016) (544-552)] doi:10.1093/rheumatology/kev373 (2017) (1)
- Connective Tissue Diseases. (1997) (1)
- AB0839 RELIABILITY OF COMPOSITE MEASURES FOR THE ASSESSMENT OF PSORIATIC ARTHRITIS (2020) (1)
- Composite Measures for Clinical Trials in Psoriatic Arthritis: Testing Pain and Fatigue Modifications in a UK Multicenter Study. (2021) (1)
- O24 Low level detection of CTD-associated autoantibodies in patients with idiopathic pulmonary fibrosis confirms this as a robust phenotype when diagnosed on clinical grounds alone (2018) (1)
- Comparison of responsiveness of BILAG-2004, SLEDAI-2000 and BILAG Systems Tally (BST). (2021) (1)
- A MULTICENTRE RELIABILITY AND VALIDITY STUDY OF LASER SPECKLE CONTRAST IMAGING AND THERMOGRAPHY IN PATIENTS WITH RAYNAUD'S PHENOMENON SECONDARY TO SYSTEMIC SCLEROSIS (2017) (1)
- 20 – CENTROMERE AUTOANTIBODIES (2007) (1)
- THU0391 Axial Disease in Psoriatic Arthritis () Study: Serum-Soluble Bone-Turnover Biomarkers of Psoriatic Arthritis Phenotypes (2016) (1)
- Response to: ‘Antisynthetase syndrome or what else? Different perspectives indicate the need for new classification criteria’ by Cavagna et al (2017) (1)
- Use of ENCODE and eQTL data to identify potential functional genetic variants at the 5q31 psoriatic arthritis susceptibility locus (2013) (1)
- 048. RISK OF UVEITIS AND INFLAMMATORY BOWEL DISEASE IN PEOPLE WITH PSORIATIC ARTHRITIS: A POPULATION-BASED COHORT STUDY (2017) (1)
- Oral abstracts 3: RA Treatment and outcomesO13. Validation of jadas in all subtypes of juvenile idiopathic arthritis in a clinical setting (2012) (1)
- The potential overlapping populations for treatment with belimumab and rituximab using current NHS England and National Institute for Health and Care Excellence Guidelines in England and Wales. (2017) (1)
- Muscle disorders111. The impact of fatigue in patients with idiopathic inflammatory myopathy: a mixed method study (2012) (1)
- Autoantibodies in Raynaud’s Phenomenon (2015) (1)
- O15. Response to Rituximab in Patients with Refractory Systemic Lupus Erythematosus (SLE): Results from a National Multi-Centre Register (2015) (1)
- Exercise and rheumatoid arthritis: what's in it for us? (2010) (1)
- O57. Autoantibody in Juvenile Dermatomyositis Reflects Disease Activity: Results of a Pilot Study (2014) (1)
- Comment on: The reliability of immunoassays to detect autoantibodies in patients with myositis is dependent on autoantibody specificity: reply. (2020) (1)
- THU0006 Application of machine learning methods for prediction modelling of psoriatic arthritis in patients with psoriasis (2018) (1)
- Genome-wide imputation identifies novel associations and localises signals in idiopathic inflammatory myopathies. (2022) (1)
- Prediction of outcomes in juvenile myositis (2016) (1)
- Spondylarthropathies (including psoriatic arthritis) 244. Validity of Colour Doppler and Spectral Doppler Ultrasound of Sacroilicac Joints Againts Physical Examination as Gold Standard (2011) (1)
- Infusion ofIloprost, a prostacyclin analogue, for treatmentofRaynaud's phenomenon insystemic sclerosis (2013) (0)
- EUROQOL-reported health disability demonstrates reduced quality of life remaining constant over time in established psoriatic arthritis (2011) (0)
- The BILAG-2004 Systems Tally-a Novel Way of Analysing the BILAG-2004 Scores (2011) (0)
- Laboratory features—enzymes and biomarkers (2018) (0)
- Diaschisis lesions following traumatic brain injury (2017) (0)
- 036. THE ILLNESS PERCEPTIONS OF PEOPLE WITH PSORIATIC ARTHRITIS: A SECONDARY ANALYSIS OF FOCUS GROUP DATA (2017) (0)
- A study of obesity, BMI, smoking and alcohol as risk factors for psoriatic arthritis (2020) (0)
- OP0224 CONTINUOUS COMPOSITE MEASURES FOR ROUTINE CARE IN PSORIATIC ARTHRITIS: THRESHOLDS OF MEANING AND CLINICALLY IMPORTANT DIFFERENCE ESTIMATES FOR THE 3 AND 4 VAS SCALES FROM A UK MULTICENTRE STUDY (2021) (0)
- 086 A longitudinal analysis of prevalence of sustained remission and low disease activity in rheumatoid arthritis patients treated with anti-tumour necrosis factor: an analysis of the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis (2018) (0)
- Gene networks describe symptom based phenotypes in primary Sjogren's syndrome (2018) (0)
- 189 Are we Optimising Therapies in Psoriatic Arthritis? A Survey of UK Practice (2016) (0)
- 220 Discrepancy between solid-phase immunoassays and immunoprecipitation in detecting anti-TIF1 gamma in patients with myositis (2019) (0)
- Sa1657: NEW LINKS BETWEEN PSORIATIC ARTHRITIS AND THE GUT MICROBIOME SUGGEST A STRONGER ROLE OF THE GUT-JOINT AXIS (2022) (0)
- IN UK CAUCASIAN ADULT AND JUVENILE-ONSET DERMATOMYOSITIS (DM), THE VITAMIN D RECEPTOR GENE (VDR) IS ASSOCIATED WITH POSSESSION OF ANTI-155/140 ANTIBODIES (2009) (0)
- 322. Patients with Refractory Systemic Lupus Erythematosus Requiring Biologic Therapy Have Significant Levels of Baseline Co-Morbidities: Results from a National Multi-Centre Register (2014) (0)
- SAT0331 CHIPPING AWAY AT POLYMYOSITIS: A RETROSPECTIVE REVIEW AT A TERTIARY MYOSITIS CENTRE (2020) (0)
- SAT0182 THE ASSOCIATION BETWEEN AUTOANTIBODIES AND RITUXIMAB RESPONSE IN SYSTEMIC LUPUS ERYTHEMATOSUS (2020) (0)
- SAT0399 RISK OF OSTEOARTHRITIS IN AN INCIDENT COHORT OF PEOPLE WITH PSORIATIC ARTHRITIS: A POPULATION-BASED COHORT STUDY (2020) (0)
- 242 Baseline characteristics of patients with lupus nephritis requiring rituximab therapy: results from the British Isles Lupus Assessment Group Biologics Register (BILAG-BR) (2019) (0)
- AB0803 EXPERIENCES OF SCREENING AND DIAGNOSIS FROM THE PERSPECTIVE OF PATIENTS WITH PSORIASIS AND PSORIATIC ARTHRITIS (PSA) (2021) (0)
- InUK Caucasian adult and juvenile onset idiopathic inflammatory myopathy (IIM), the PTPN22 1858 -> T polymorphism confers disease susceptibility independent of HLA-DRB1*03 (2008) (0)
- Frequency andclinical associations ofanti-chromo antibodies inconnective tissue disease (1994) (0)
- Development and testing of new candidate psoriatic arthritis screening questionnaires combining optimal questions from existing tools Authors (2015) (0)
- IX Eular Workshop for Rheumatology Research (1989) (0)
- Comment on: The reliability of immunoassays to detect autoantibodies in patients with myositis is dependent on autoantibody specificity: reply. (2020) (0)
- i065 The diagnostic utility of interstitial lung disease serology (2018) (0)
- Influence of the cold challenge on the discriminatory capacity of the digital distal-dorsal thermal gradient in the thermographic assessment of Raynaud's phenomenon (2011) (0)
- O55. Prevalence of Autoantibodies to Hmgcr in Myositis Patients (2014) (0)
- Clinical associations of autoantibodies to a p155/140kDa doublet in adult dermatomyositis is a major autoantigen target in juvenile dermatomyositis (2007) (0)
- MATTERS ARISING Effect of gold treatment on cytokine expression in synovium (0)
- Psoriatic arthritis screening tools: study design and methodologic challenges – reply from authors (2014) (0)
- POS0111 DEVELOPMENT OF DAMAGE AND MORTALITY IN AN INCEPTION COHORT OF SLE PATIENTS (2021) (0)
- BSRBR-RA Contributors Group (2019). Early response to anti-TNF predicts long-term outcomes including sustained remission: an analysis of the BSRBR-RA. Rheumatology , (2019) (0)
- Ro52, Myositis, and Interstitial Lung Disease (2022) (0)
- Plain radiography (2018) (0)
- Symptoms and diagnosis of psoriatic arthritis (2013) (0)
- Methotrexate in Psoriatic Arthritis : Results from 2 Clinical Trials Comparison of Etanercept Monotherapy and Combination Therapy with and Gaia (2016) (0)
- The BILAG-2004 index is associated with development of new damage in SLE. (2022) (0)
- Investigating a Novel Locus For Psoriatic Arthritis (2013) (0)
- Adalimumab treatment is effective in patients with psoriatic arthritis (PSA) in day-to-day clinical practice - Results from the stereo trial (2008) (0)
- A new era for collaboration? (2018) (0)
- Concurrent Oral 6 – Spondylarthropathies [OP40–OP47] OP40. Association of IL23R and IL12B Polymorphisms with Psoriatic Arthritis (2010) (0)
- Vacuum assisted closure therapy:A novel treatment for refractory digital ulceration in systemic sclerosis (2010) (0)
- POS0288 A KEY TIF1γ EPITOPE MAY FACILITATE THE IDENTIFICATION OF PATIENTS AT HIGHEST RISK OF CANCER ASSOCIATED MYOSITIS (2021) (0)
- OA30 Systemic sclerosis and cancer in the UK: an epidemiological analysis using the Clinical Practice Research Datalink (2023) (0)
- Sub-phenotyping of juvenile dermatomyositis (2015) (0)
- CHARACTERISATION OF UK ANTI-HMGCR+ ANTIBODY ASSOCIATED MYOSITIS (2016) (0)
- Laboratory Tests for Psoriatic Arthritis (2016) (0)
- Treatments for psoriatic arthritis (2006) (0)
- Preliminary Rasch analysis of SLEDAI-2000 index: An ordinal scale index with internal construct validity (2006) (0)
- Clinical and Autoantibody Associations in Myositis Patients with Anti p155/140kDa Autoantibodies - A Multicenter European Study (2011) (0)
- SAT0011 Replication of A Distinct Psoriatic Arthritis Risk Variant at IL23R (2016) (0)
- 68. PROGRESSION OF FUNCTIONAL DISABILITY IN PSORIATIC ARTHRITIS: A COMPARISON OF CONVENTIONAL DMARDS AND ANTI-TNF THERAPY (2010) (0)
- Advancing research paradigms and pathophysiological pathways in psoriatic arthritis and ankylosing spondylitis: Proceedings of the 2017 Platform for the Exchange of Expertise and Research (PEER) meeting. (2019) (0)
- Risk of Osteoarthritis in an Incident Cohort of People With Psoriatic Arthritis: A Population-based Cohort Study (2020) (0)
- Concurrent oral 4 – Connective tissue disease OP22. B Cell Numbers and Phenotype at Clinical Relapse Following Rituximab Therapy Differ in SLE Patients According to Anti-Dsdna Antibody Titres (2011) (0)
- POS0106 BILAG-2004 LDA AND BST LDA ARE VALID TREAT TO TARGET IN SLE (2021) (0)
- Authors' reply (1995) (0)
- P163 Association between biomarkers and therapeutic pathway in patients with SLE (2021) (0)
- Response to Rituximab in Patients with Refractory Systemic Lupus Erythematosus (SLE): Results from a National Multicentre Register (2014) (0)
- A NEGATIVE RHEUMATOID FACTOR RESULT IN PRIMARY CARE SIGNIFICANTLY DELAYS THE TIME TO DIAGNOSIS OF RHEUMATOID ARTHRITIS: A STUDY USING THE CLINICAL PRACTICE RESEARCH DATALINK (2015) (0)
- 069. CONSTRUCT VALIDITY, RESPONSIVENESS AND MINIMALLY IMPORTANT DIFFERENCE OF THE ROUTINE ASSESSMENT OF PATIENT INDEX DATA 3 IN PSORIATIC ARTHRITIS (2017) (0)
- FRI0218 IMMUNOPHENOTYPIC SUBGROUPS OF SLE DEFINED BY AUTOANTIBODIES, GENE EXPRESSION AND FLOW CYTOMETRIC ANALYSIS (2019) (0)
- Autoantibodies in juvenile dermatomyositis, scleroderma and overlap syndromes (2006) (0)
- BHPR: Audit and Clinical Evaluation103. Dental Health in Children and Young Adults with Inflammatory Arthritis: Access to Dental Care (2013) (0)
- A novel composite radiographic score for longitudinal observational studies of Psoriatic Arthritis: Reductive X-ray Score for Psoriatic Arthritis (ReXSPA)- a proof of concept study (2016) (0)
- Autoantibody Associations Arthritis in Idiopathic Inflammatory Myopathy: Clinical Features and (2014) (0)
- Systemic sclerosis: HLA antigens, autoantibodies and the brain. (1994) (0)
- Preliminary Validation of the Severity of Nail Psoriasis Score (SNAPS) for the Assessment of Nail Psoriasis in Patients With Psoriatic Arthritis (2021) (0)
- CONNECTIVE TISSUE DISORDERS AND VASCULITIS ORAL ABSTRACTSO13. AUTOANTIBODY SUBTYPE IN PATIENTS WITH JUVENILE-ONSET MYOSITIS INFLUENCES TREATMENT RECEIVED (2017) (0)
- PReS-FINAL-2130: Antibodies to MDA5 correlate with a distinct phenotype in children with juvenile dermatomyositis, including higher risk of lung involvement and ulcerative skin disease (2013) (0)
- O54 Differences in DAS28-CRP and DAS28-ESR Influence Disease Activity Stratification in Rheumatoid Arthritis and Could Influence the Use of Biologics, Treatment Efficacy Evaluations and Decisions Regarding Treat-To-Target: An Analysis Using the British Society for Rheumatology Rheumatoid Arthritis R (2016) (0)
- Basic science232. Certolizumab pegol prevents pro-inflammatory alterations in endothelial cell function (2012) (0)
- 117 Anti-TIF-1 antibody positivity is associated with a five-fold increase in cancer risk in the idiopathic inflammatory myopathies (2018) (0)
- Anti-TIF-1 Antibody Positivity Is Associated with a Five-Fold Increase in Cancer Risk in the Idiopathic Inflammatory Myopathies (2017) (0)
- 肥胖、BMI、吸烟和饮酒作为银屑病关节炎风险因素的研究 (2020) (0)
- The Journal of Rheumatology Interphalangeal Joints in Psoriatic Arthritis: A Retrospective Cohort Study Psoriatic Nail Dystrophy Is Associated with Erosive Disease in the Distal (2019) (0)
- 201 Retrospective Study of the Management of Psoriatic Arthritis with Tumour Necrosis Factor Inhibitors in the UK: Capture Study Preliminary Analysis (2016) (0)
- Executive summary: The 2022 British Society for Rheumatology guideline for the treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs. (2022) (0)
- The Journal of Rheumatology Interphalangeal Joints in Psoriatic Arthritis: A Retrospective Cohort Study Psoriatic Nail Dystrophy Is Associated with Erosive Disease in the Distal (2019) (0)
- Genetic association study of NF-KB genes in UK Caucasian adult and juvenile onset idiopathic inflammatory myopath (IIM) (2008) (0)
- BILAG-2004 index: A reliable tool for assessment of SLE activity (2005) (0)
- OP0128 PTPN22 is Associated with Susceptibility to Psoriatic Arthritis but not Psoriasis: Evidence for a Further PSA-Specific Risk Locus (2015) (0)
- The 'Severity of Nail Psoriasis Score' (SNAPS) Is Feasible, Reliable and Demonstrates Construct Validity Against the mNAPSI in an Observational Cohort of Patients with Psoriatic Arthritis (2019) (0)
- Systemic lupus erythematosus: a pragmatic guide to current management IP49. Diagnosing and Treating Systemic Lupus Erythematosus (2011) (0)
- O47 A Dense Fine Speckle Pattern on Immunofluorescence is Strongly Associated with the Development of Uveitis in Children with Juvenile Idiopathic Arthritis (2016) (0)
- AB0736 SEVERITY OF NAIL PSORIASIS SCORE (SNAPS) IS SENSITIVE TO CHANGE IN A COHORT OF PATIENTS WITH PSORIATIC ARTHRITIS TREATED WITH ETANERCEPT (2020) (0)
- Frequencies of TNF alpha, TNF alpha receptor and IL-6 polymorphism in ANCA associated vasculitis (2003) (0)
- HLA-DPB1*0101 associations in UK Caucasian adult and juvenile idiopathic inflammatory myopathy patients. (2008) (0)
- 319. Gender Differences Between Patient Self-Reporting of Raynaud’s Phenomenon and Objective Assessment of Digital Microvascular Perfusion Using Infrared Thermography (2014) (0)
- A multicentre study of validity and reliability of measures of cold challenge measured by LSCI and thermography: outcome measures for SSc-related RP (2018) (0)
- 187 Improvement of psoriatic nail disease in psoriatic arthritis patients treated with adalimumab: results of an observational cohort up to 36 months (2018) (0)
- Oral abstracts 1: SpondyloarthropathiesO1. Detecting axial spondyloarthritis amongst primary care back pain referrals (2012) (0)
- BILAG-2004 captures SLE disease activity better than SLEDAI-2000 (2005) (0)
- Correction to: Important Treatment Outcomes for Patients with Psoriatic Arthritis: A Multisite Qualitative Study (2019) (0)
- 294 Immunophenotypic subgroups of SLE defined by autoantibodies, gene expression and flow cytometric analysis (2019) (0)
- I112 New Drugs for Psoriatic Arthritis: The Rheumatologists Perspective—To Include Apremilast, Ustekinumab and Secukinumab (2016) (0)
- CHARACTERISTICS OF PATIENTS WITH REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS REQUIRING BIOLOGIC THERAPY IN A UK MULTICENTRE COHORT (2013) (0)
- 205. The UK Primary Sjögren’s Syndrome Registry (UKPSSR): A Valuable Resource for Future Sjögren’s Syndrom Research (2014) (0)
- Genetics [315–318]315. Investigation of Association of the Erap1 Gene with Psoriatic Arthritis (2010) (0)
- P265 Burden of psoriatic nail disease and response to biologic therapy in a PsA cohort (2020) (0)
- Inflammatory myositis - Foray into the future (2020) (0)
- Biopsy pathology in a large cohort of juvenile dermatomyositis is heterogeneous and, for the most part, independent of autoantibody phenotype (2017) (0)
- Spondyloarthropathies (Including Psoriatic Arthritis) [40–69] 40. Eagle's Syndrome: An Unusual Association with Sero-Negative Arthropathy (2010) (0)
- A qualitative study of patients’ experiences of screening for psoriatic arthritis (2022) (0)
- THU0251 IMMUNOPHENOTYPIC CLUSTERS OF SLE PATIENTS REVEAL SUBGROUPS WITH SEVERE DISEASE RESISTANT TO CONVENTIONAL THERAPY (2020) (0)
- Patient-centred standards of care for adults with myositis (2017) (0)
- Temporal recogntion of epitopes on the sm b polypeptide in two patients (1993) (0)
- 093 Factors Associated with Sustained Remission in Rheumatoid Arthritis in Patients Treated with Anti-Tumour Necrosis Factor: A Systematic Review (2016) (0)
- Molecular mechanisms of disease: osteoarthritisI68. Osteoarthritis (2012) (0)
- AB1241 EVALUATION OF A PATIENT COMPLETED DISEASE FLARE QUESTIONNAIRE IN PSORIATIC DISEASE (2020) (0)
- POS0705 BILAG-2004 INDEX ACTIVE DISEASE PREDICTS DEVELOPMENT OF DAMAGE (2021) (0)
- Newly Described Myositis Autoantibodies: HMGCR, NT5C1A, SAE, PUF60 (2019) (0)
- Essentials in rheumatology IP1. Disease Management: Management of Behçet’s Syndrome (2011) (0)
- Next generation sequencing of RNA from muscle biopsies shows marked differences between inflammatory myositis, inclusion body myositis, and controls (2013) (0)
- 47. Specialist Commissioning: Does Treatment by Experts Influence Outcomes for Patients with Rare Diseases? An Exemplar from Myositis (2014) (0)
- A p155/140 kDa cancer-associated autoantigen in adult dermatomyositis is a major autoantigen target in juvenile dermatomyositis (2007) (0)
- P264 Burden of disease and relative impact of skin and joint disease on quality of life in PsA: analysis from a UK secondary care cohort (2020) (0)
- 219 Validation of a Distinct Psoriatic Arthritis Risk Variant at IL23R (2016) (0)
- The use of ELISA is comparable to immunoprecipitation in the detection of selected myositis-specific autoantibodies in a European population (2022) (0)
- Clinical Image: skin hyperpigmentation over inflamed joints. (2006) (0)
- Health services research, economics and outcomes research 52. Reducing New-to-Follow-up Ratios: No More Easy Solutions (2011) (0)
- The Journal of Rheumatology of Psoriatic Arthritis: A Proof-of-concept Study Novel Composite Radiographic Score for Longitudinal Observational Studies (2015) (0)
- BILAG BIOLOGICS PROSPECTIVE COHORT: THE USE OF NOVEL BIOLOGICAL THERAPIES IN THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS IN THE UNITED KINGDOM (2012) (0)
- Infections Observed in Rituximab Treated Patients with Refractory Systemic Lupus Erythematosus (SLE): Results from a National Multicentre Register (2015) (0)
- POS1034 RESPONSE TO SEQUENTIAL LINES OF BIOLOGICAL THERAPY IN PSORIATIC ARTHRITIS: A SINGLE CENTRE COHORT STUDY (2021) (0)
- THU0004 Cross phenotype association mapping of the mhc identifies genetic variants that differentiate psoriatic arthritis from psoriasis (2017) (0)
This paper list is powered by the following services: